Literature DB >> 15840114

Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature.

H S Beltraminelli1, M Lerch, A Arnold, A J Bircher, P Haeusermann.   

Abstract

Cutaneous drug reactions occur with a frequency of 1-8% and can be higher for certain classes of drugs. They can range from mild morbilliform eruptions to more severe forms such as drug-hypersensitivity syndrome, toxic epidermal necrolysis or anaphylaxis. Acute generalized exanthematous pustulosis (AGEP) is considered to be a clinical reaction pattern, which is induced in over 90% of the cases by systemic drugs. It is a rare presentation of an adverse drug reaction most frequently triggered by anti-infectious drugs. A high proportion of these cases have been attributed to aminopenicillins and macrolides. We report a terbinafine-induced AGEP in a 68-year-old male confirmed by lymphocyte stimulation in vitro, and review the published cases induced by antimycotic drugs with special emphasis on terbinafine-triggered cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840114     DOI: 10.1111/j.1365-2133.2005.06393.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

1.  Fluconazole-induced acute generalized exanthematous pustulosis.

Authors:  Vito Di Lernia; Cinzia Ricci
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

2.  Acute generalized exanthematous pustulosis caused by diltiazem.

Authors:  Hyun-Je Kim; Kyu-Dong Jung; Kyung-Tae Lee; Ji-Yeon Byun; Dong-Youn Lee; Joo-Heung Lee; Jun-Mo Yang; Eil-Soo Lee
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

3.  Acute Generalized Exanthematous Pustulosisafter Ingestion of Lacquer Chicken.

Authors:  Min Young Park; Hee Young Kang
Journal:  Ann Dermatol       Date:  2008-12-31       Impact factor: 1.444

4.  [Acute generalized exanthematous pustulosis with confirmed type IV allergy. Report of 3 cases].

Authors:  K Gensch; N Hodzic-Avdagic; M Megahed; T Ruzicka; A Kuhn
Journal:  Hautarzt       Date:  2007-03       Impact factor: 0.751

5.  Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine.

Authors:  Fouad Mitri; Ferdinand Toberer; Alexander H Enk; Martin Hartmann
Journal:  Acta Derm Venereol       Date:  2021-11-17       Impact factor: 3.875

Review 6.  [Terbinafine : Drug-induced lupus erythematodes and triggering of psoriatic skin lesions].

Authors:  P Mayser
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

Review 7.  [Adverse drug reactions and the skin--from trivial to fire signal].

Authors:  K Scherer; A Bircher
Journal:  Internist (Berl)       Date:  2009-02       Impact factor: 0.743

8.  [Acute generalized exanthematous pustulosis].

Authors:  A Sidoroff
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

9.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

10.  Acute generalized exanthematous pustulosis x Von Zumbusch's pustular psoriasis: a diagnostic challenge in a psoriatic patient.

Authors:  Aline Soares de Sousa; Osório Alves Corrêa de Castro Lara; Francine Papaiordanou; Gláucia Silva Simioni Marchioro; Antonio José Tebcherani
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.